3/28
08:20 am
dtil
Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
Report
Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
3/19
12:38 pm
dtil
Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
Low
Report
Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
2/19
11:42 am
dtil
Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
Low
Report
Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
1/10
08:03 am
dtil
Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
High
Report
Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
1/10
08:01 am
dtil
Precision BioSciences, Inc. (NASDAQ: DTIL) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $34.00 price target on the stock.
High
Report
Precision BioSciences, Inc. (NASDAQ: DTIL) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $34.00 price target on the stock.
1/10
05:44 am
dtil
Rating for DTIL
Medium
Report
Rating for DTIL
1/10
05:44 am
dtil
Rating for DTIL
Medium
Report
Rating for DTIL
1/10
04:36 am
dtil
Precision BioSciences upgraded to Outperform from Market Perform at BMO Capital
Medium
Report
Precision BioSciences upgraded to Outperform from Market Perform at BMO Capital
1/10
04:36 am
dtil
Precision BioSciences upgraded to Outperform from Market Perform at BMO Capital
Medium
Report
Precision BioSciences upgraded to Outperform from Market Perform at BMO Capital